On Purpose with Jay Shetty
Also in Health & Fitness
Science
Lung Cancer Update
by Dr. Neil Love
Today: #182 in Science, New Zealand on our combined chart.
Chart positions today · New Zealand
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Lung Cancer Update, try…
The Mel Robbins Podcast
Also in Health & Fitness
The Checkup with Doctor Mike
Also in Medicine
Huberman Lab
Also in Science
Oncology Today with Dr Neil Love
From Dr. Neil Love
This Week in Virology
Also in Medicine
Ranking history · New Zealand
History builds daily. We started tracking this show on the Science, New Zealand chart recently, so the trend line appears after a second day of data.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 11 | #182 | #182 |
Latest episodes
-
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
October 4, 2026 · 51 minFeaturing perspectives from Dr Stephen V Liu and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: Introduction (0:00)EGFR Mutations (2:23)HER2 Alterations (22:40)Available and Investigational…
-
For Oncology Nurses: Non-Small Cell Lung Cancer with a ROS1 Fusion — An Interview with Dr Alexander E Drilon
September 30, 2026 · 58 minFeaturing an interview with Dr Alexander E Drilon, including the following topics: Overview of targetable biomarkers in lung cancer (0:00)Biomarker testing for genomic alterations in lung cancer (5:24)Overview of ROS1 alterations in lung…
-
Non-Small Cell Lung Cancer — Targeting KRAS G12C
September 10, 2026 · 58 minFeaturing perspectives from Prof Solange Peters and Dr Joshua K Sabari, including the following topics: Introduction (0:00)Best Option for Your Patient (1:28)Biological Considerations (6:26)KRAS G12C Inhibitors (11:33)Second-Line Treatment…
-
Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer — An Interview with Prof Ticiana Leal
September 1, 2026 · 55 minFeaturing an interview with Prof Ticiana Leal, including the following topics: Pathophysiology and clinical signs and symptoms (0:00)Screening and/or diagnostic approaches (5:45)Potential impact of available therapies for small cell lung…
-
Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
August 7, 2026 · 1 hr 59 minFeaturing perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics: Introduction (0:00)Optimizing First-Line and Maintenance Therapy for…
Show 7 more episodesShow fewer episodes
-
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
August 4, 2026 · 59 minFeaturing perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics: Introduction: Relative Impact of Targeted Treatment (00:00)HER2 Alterations (8:04)KRAS Mutations (24:25)MET Overexpression (30:34)ALK…
-
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 3
July 30, 2026 · 30 minFeaturing perspectives from Dr Joshua K Sabari, including the following topics: Jänne PA et al. Final analysis results and patient-reported outcomes from DESTINY-Lung02 — A dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan…
-
HER2-Altered Non-Small Cell Lung Cancer — 5-Minute Journal Club: Microlearning Activity 2
July 30, 2026 · 17 minFeaturing perspectives from Dr Joshua K Sabari, including the following topics: Heymach JV et al. Zongertinib in previously treated HER2-mutant non-small cell lung cancer. N Engl J Med 2025;392(23):2321-33. (0:00)Popat S et al. Zongertinib…
-
EGFR-Mutated Non-Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
July 21, 2026 · 1 hr 58 minFeaturing perspectives from Dr Sarah B Goldberg, Dr Jonathan Goldman, Dr Joel W Neal, Dr Antonio Passaro and Dr Jacob Sands, moderated by Dr Sands, including the following topics: Introduction (00:00)Evolving First-Line Treatment for…
-
HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review
July 14, 2026 · 28 minFeaturing an interview with Dr Mark Jeng and Dr Joshua K Sabari, including the following topics: Case: A woman in her late 90s with recurrent HER2-mutant metastatic non-small cell lung cancer (NSCLC) receives third-line zongertinib…
-
Nonmetastatic Non-Small Cell Lung Cancer — An Interview with Dr Jamie E Chaft
July 11, 2026 · 60 minFeaturing an interview with Dr Jamie E Chaft, including the following topics: Case: A man in his early 70s with a 40 to 50 pack-year history of smoking and cT2bN1 squamous cell carcinoma of the lung with PD-L1 60% treated with induction…
-
For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress
July 8, 2026 · 1 hr 29 minFeaturing perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics: Introduction (0:00)Overview of Antibody-Drug Conjugates…
About the show
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.